2023
Neurofeedback for obsessive compulsive disorder: A randomized, double-blind trial
Rance M, Zhao Z, Zaboski B, Kichuk S, Romaker E, Koller W, Walsh C, Harris-Starling C, Wasylink S, Adams T, Gruner P, Pittenger C, Hampson M. Neurofeedback for obsessive compulsive disorder: A randomized, double-blind trial. Psychiatry Research 2023, 328: 115458. PMID: 37722238, PMCID: PMC10695074, DOI: 10.1016/j.psychres.2023.115458.Peer-Reviewed Original ResearchMeSH KeywordsAnxietyDouble-Blind MethodHumansNeurofeedbackObsessive-Compulsive DisorderPrefrontal CortexTreatment OutcomeConceptsObsessive-compulsive disorderAnterior prefrontal cortexControl groupDouble-blind clinical trialDouble-blind trialPrimary outcome measureCompulsive disorderHarm/checkingMechanism of actionYale-Brown ObsessiveSecondary outcomesSessions of neurofeedbackActive groupClinical trialsOutcome measuresPrimary symptomsSymptom ScaleObsessive-compulsive symptomsPrefrontal cortexSymptomsTraining protocolGreater reductionSignificant differencesPatientsSham feedback
2019
Group exposure and response prevention for college students with social anxiety: A randomized clinical trial
Zaboski B, Joyce‐Beaulieu D, Kranzler J, McNamara J, Gayle C, MacInnes J. Group exposure and response prevention for college students with social anxiety: A randomized clinical trial. Journal Of Clinical Psychology 2019, 75: 1489-1507. PMID: 31022313, DOI: 10.1002/jclp.22792.Peer-Reviewed Original Research